Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending August 2015. The document serves as a notification of transactions involving directors and persons discharging managerial responsibilities (PDMRs) or their connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a regulatory disclosure of a specific share transaction and does not contain financial performance data.
Material Changes
The filing details a pro-rata cancellation of 684,056 Ordinary Shares under the GlaxoSmithKline 2009 Performance Share Plan (PSP). This cancellation was triggered by the termination of employment of a Connected Person (Mrs. K Thomson) on February 10, 2015, in accordance with the plan's leaver rules. The transaction was advised to the company on July 31, 2015.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the specific share cancellation event described.
Investor Verification Points
- Verify the impact of the 684,056 share cancellation on the total outstanding share count.
- Confirm the specific terms of the 2009 Performance Share Plan regarding leaver rules.
- Review the identity and role of the PDMR (Mr. P Thomson) and the Connected Person (Mrs. K Thomson) involved in the transaction.